Pharmaceutical Analytical Impurities - PAI

We are very pleased that you are interested in PAI.

Pharmaceutical Analytical Impurities, or PAI, are a new product development of the American USP.
PAI products provide a comprehensive solution for identifying non-USP Reference Standards impurities in your research and analytical needs.

PAIs help you produce high-quality drug products and are released in a separate process by USP experts in compliance with USP‘s rigorous quality management (ISO 9001:2015 certified).

• Increase safety in Active Pharmaceutical Ingredients (API) or drug product releases by testing also for impurities that are not (yet) listed in a monograph.
• Comparison and determination of degradation impurities generated during loading studies.
• Identification of unknown impurities that arose during ICH stability conditions.
• Identification of impurities in the reference drug product.
• Realization of complementary analytical tests during early formulation feasibility studies.
• Time savings in the development and manufacture of high-quality drug products.

We would be glad to send you further information material and an overview of PAI articles already available in the webshop www.reference-standards.com. Simply fill in the contact fields below or send us a short e-mail with the subject „PAI“ to reference-standards@phast.com.

Eurofins PHAST supplies Reference Standards and PAI exclusively to professional staff (pharmaceutical industry - e.g. manufacturers of originator and generic products as well as phytopharmaceuticals, institutional laboratories, pharmacies).